DSIP Dosing & Reconstitution Guide
Dosing Protocol
Route: Subcutaneous or Intramuscular Frequency: Once daily (typically before bed) Dose Range: 50–200 mcg SC before bed Cycle Length: 4–8 weeks; short cycles recommended due to limited human data Timing: 30 minutes before bed
Reconstitution
Vial Size: 5mg Water Volume: 2.5mL Concentration: 2mg/mL
Titration Schedule
Weeks 1–2: 50 mcg before bed Weeks 3+: 100–200 mcg before bed
Storage
Lyophilized: −20 °C (−4 °F) Reconstituted: 2–8 °C (35.6–46.4 °F) Shelf Life: 28 days
Injection Sites
Abdomen, Thigh
Safety & Contraindications
Safety: Well-tolerated in research settings with minimal adverse effects reported Occasional mild dizziness or nausea, typically resolving within a short period Short half-life in blood -- rapid enzymatic degradation
Contraindications: No established contraindications (due to lack of comprehensive data); Pregnancy and breastfeeding (no safety data); Caution with CNS depressants (potential additive sedation based on mechanism)